Circadian Disruption and Breast Cancer: From Melatonin to Clock Genes
暂无分享,去创建一个
[1] Charles A Czeisler,et al. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. , 2003, The Journal of clinical endocrinology and metabolism.
[2] T. Yoshimura,et al. Spectral sensitivity of photoreceptors mediating phase-shifts of circadian rhythms in retinally degenerate CBA/J (rd/rd) and normal CBA/N (+/+) mice , 1996, Journal of Comparative Physiology A.
[3] C. Nagata,et al. Trends in the incidence rate and risk factors for breast cancer in Japan , 1997, Breast Cancer Research and Treatment.
[4] Tore Tynes,et al. Incidence of breast cancer in Norwegian female radio and telegraph operators , 1996, Cancer Causes & Control.
[5] S H Moolgavkar,et al. Temporal trends in breast cancer. , 1982, American journal of epidemiology.
[6] David E. Blask,et al. Growth and Fatty Acid Metabolism of Human Breast Cancer (MCF-7) Xenografts in Nude Rats: Impact of Constant Light-Induced Nocturnal Melatonin Suppression , 2003, Breast Cancer Research and Treatment.
[7] David E. Blask,et al. Pineal melatonin inhibition of tumor promotion in theN-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo , 2005, Journal of Cancer Research and Clinical Oncology.
[8] I. Fentiman,et al. Melatonin and breast cancer: a prospective study. , 2004, Journal of the National Cancer Institute.
[9] B. H. Miller,et al. Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock , 2002, Cell.
[10] H. Ra. Does blindness protect against cancers , 1998 .
[11] D. Blask,et al. Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway. , 1997, Cancer research.
[12] J. Horne,et al. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. , 1976, International journal of chronobiology.
[13] L. Fu,et al. The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.
[14] B. Macmahon. Cohort fertility and increasing breast cancer incidence , 1958, Cancer.
[15] Johnni Hansen,et al. Increased Breast Cancer Risk among Women Who Work Predominantly at Night , 2001, Epidemiology.
[16] J. Rizzo,et al. Suppression of melatonin secretion in some blind patients by exposure to bright light. , 1995, The New England journal of medicine.
[17] A C Bird,et al. Relationship between melatonin rhythms and visual loss in the blind. , 1997, The Journal of clinical endocrinology and metabolism.
[18] R. Foster,et al. Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors. , 1999, Science.
[19] Josephine Arendt,et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. , 2003, Sleep.
[20] N. Kajimura,et al. Alleic variants of human melatonin 1a receptor: function and prevalence in subjects with circadian rhythm sleep disorders. , 1999, Biochemical and biophysical research communications.
[21] W Gruen,et al. Seasonal Variation in Human Illumination Exposure at Two Different Latitudes , 1995, Journal of biological rhythms.
[22] D. Trichopoulos. Hypothesis: does breast cancer originate in utero? , 1990, The Lancet.
[23] R. Stevens,et al. Electric power use and breast cancer: a hypothesis. , 1987, American journal of epidemiology.
[24] G. Brainard,et al. Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor , 2001, The Journal of Neuroscience.
[25] Francis Lévi,et al. Host circadian clock as a control point in tumor progression. , 2002, Journal of the National Cancer Institute.
[26] M. Lippman,et al. ROLE OF PINEAL GLAND IN ÆTIOLOGY AND TREATMENT OF BREAST CANCER , 1978, The Lancet.
[27] R. V. Van Gelder. Making (a) sense of non-visual ocular photoreception. , 2003, Trends in neurosciences.
[28] S. Pocock,et al. Incidence , , 2018 .
[29] M Feychting,et al. Reduced Cancer Incidence among the Blind , 1998, Epidemiology.
[30] F. Bray,et al. Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.
[31] L. E. Anderson,et al. Effect of constant light on DMBA mammary tumorigenesis in rats , 2000, Cancer Letters.
[32] R. Stevens,et al. Inverse association between breast cancer incidence and degree of visual impairment in Finland , 1999, British Journal of Cancer.
[33] D. P. King,et al. A CLOCK polymorphism associated with human diurnal preference. , 1998, Sleep.
[34] R. Hahn,et al. Profound bilateral blindness and the incidence of breast cancer. , 1991, Epidemiology.
[35] B. Griefahn. The validity of the temporal parameters of the daily rhythm of melatonin levels as an indicator of morningness , 2002, Chronobiology international.
[36] T. Wehr,et al. Photoperiodism in Humans and Other Primates: Evidence and Implications , 2001, Journal of biological rhythms.
[37] Peng Huang,et al. The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo , 2002, Cell.
[38] P. Siiteri,et al. Placental characteristics and reduced risk of maternal breast cancer. , 2001, Journal of the National Cancer Institute.
[39] L. E. Anderson,et al. Electric power, pineal function, and the risk of breast cancer , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] R. Troisi,et al. In-utero and early life exposures in relation to risk of breast cancer , 1999, Cancer Causes & Control.
[41] Michael Menaker,et al. Circadian Photoreception , 2003, Science.
[42] Tongzhang Zheng,et al. Period3 structural variation: a circadian biomarker associated with breast cancer in young women. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[43] S. Hill,et al. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. , 1992, Cancer letters.
[44] Mark S. Rea,et al. Light in the Built Environment: Potential role of Circadian Disruption in Endocrine Disruption and Breast Cancer , 2001, Cancer Causes & Control.
[45] M. Karásek,et al. Melatonin in humans. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[46] G. Maestroni,et al. Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer. , 1999, Advances in experimental medicine and biology.
[47] D A Newsome,et al. Light suppresses melatonin secretion in humans. , 1980, Science.
[48] A. Auvinen,et al. Incidence of cancer among Finnish airline cabin attendants, 1967-92 , 1995, BMJ.
[49] J. Russo,et al. Mammary gland neoplasia in long-term rodent studies. , 1996, Environmental health perspectives.
[50] Prahlad T. Ram,et al. Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells , 2004, Breast Cancer Research and Treatment.
[51] R. N. Gelder. Making (a) sense of non-visual ocular photoreception , 2003, Trends in Neurosciences.
[52] R. Kronauer,et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. , 1999, Science.
[53] B. Griefahn,et al. Melatonin synthesis: a possible indicator of intolerance to shiftwork. , 2002, American journal of industrial medicine.
[54] R. Reiter,et al. Melatonin: an antioxidant in edible plants. , 2002, Annals of the New York Academy of Sciences.
[55] J. West,et al. Developmental Alcohol and Circadian Clock Function , 2001, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.
[56] R. Stevens. Epidemiology of Uriniary Melatonin in Women and Its Relation to Other Hormones and Night Work , 2005, Cancer Epidemiology Biomarkers & Prevention.
[57] T. Mack,et al. Puberty and genetic susceptibility to breast cancer in a case-control study in twins. , 2003, The New England journal of medicine.
[58] F Laden,et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. , 2001, Journal of the National Cancer Institute.
[59] M. Mhatre,et al. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. , 1984, Cancer research.
[60] T. Paunio,et al. Circadian Clock-Related Polymorphisms in Seasonal Affective Disorder and their Relevance to Diurnal Preference , 2003, Neuropsychopharmacology.
[61] G. Eichele,et al. The mPer2 gene encodes a functional component of the mammalian circadian clock , 1999, Nature.
[62] R. Stevens,et al. Night shift work, light at night, and risk of breast cancer. , 2001, Journal of the National Cancer Institute.
[63] Cantab Ma. John Crighton Bramwell. , 1976 .
[64] T. Tynes,et al. Risk of breast cancer among Norwegian women with visual impairment , 2001, British Journal of Cancer.